troglitazone has been researched along with Carcinoma, Renal Cell in 5 studies
Troglitazone: A chroman and thiazolidinedione derivative that acts as a PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS (PPAR) agonist. It was formerly used in the treatment of TYPE 2 DIABETES MELLITUS, but has been withdrawn due to hepatotoxicity.
Carcinoma, Renal Cell: A heterogeneous group of sporadic or hereditary carcinoma derived from cells of the KIDNEYS. There are several subtypes including the clear cells, the papillary, the chromophobe, the collecting duct, the spindle cells (sarcomatoid), or mixed cell-type carcinoma.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| von Schwarzenberg, K | 1 |
| Held, SA | 1 |
| Schaub, A | 1 |
| Brauer, KM | 1 |
| Bringmann, A | 1 |
| Brossart, P | 1 |
| Fujita, M | 1 |
| Yagami, T | 1 |
| Fujio, M | 1 |
| Tohji, C | 1 |
| Takase, K | 1 |
| Yamamoto, Y | 1 |
| Sawada, K | 1 |
| Yamamori, M | 1 |
| Okamura, N | 1 |
| Yang, FG | 2 |
| Zhang, ZW | 2 |
| Xin, DQ | 2 |
| Shi, CJ | 2 |
| Wu, XQ | 1 |
| Liu, WJ | 1 |
| Guo, YL | 2 |
| Wu, JP | 2 |
| Guan, YF | 1 |
| Inoue, K | 1 |
| Kawahito, Y | 1 |
| Tsubouchi, Y | 1 |
| Kohno, M | 1 |
| Yoshimura, R | 1 |
| Yoshikawa, T | 1 |
| Sano, H | 1 |
5 other studies available for troglitazone and Carcinoma, Renal Cell
| Article | Year |
|---|---|
Proteasome inhibition overcomes the resistance of renal cell carcinoma cells against the PPARgamma ligand troglitazone.
Topics: Angiogenesis Inducing Agents; Antineoplastic Agents; Apoptosis; Boronic Acids; Bortezomib; Carcinoma | 2009 |
Cytotoxicity of troglitazone through PPARĪ³-independent pathway and p38 MAPK pathway in renal cell carcinoma.
Topics: Antineoplastic Agents; Blotting, Western; Carcinoma, Renal Cell; Cell Line, Tumor; Chromans; Humans; | 2011 |
[Peroxisome proliferator-actived receptor-gamma ligand troglitazone induces apoptosis in renal cell carcinoma].
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Renal Cell; Cell Line, Tumor; Chromans; Humans; Kidney | 2004 |
Peroxisome proliferator-activated receptor gamma ligands induce cell cycle arrest and apoptosis in human renal carcinoma cell lines.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Proliferation; Chrom | 2005 |
Expression of peroxisome proliferator-activated receptor gamma in renal cell carcinoma and growth inhibition by its agonists.
Topics: Antineoplastic Agents; Blotting, Western; Carcinoma, Renal Cell; Cell Division; Chromans; Coloring A | 2001 |